Generated by GPT-5-mini| Agence Régionale de Santé (ARS) | |
|---|---|
| Name | Agence Régionale de Santé |
| Formation | 2010 |
| Type | Public administrative institution |
| Headquarters | Paris, France |
| Region served | France |
| Parent organization | Ministère des Solidarités et de la Santé |
Agence Régionale de Santé (ARS) The Agence Régionale de Santé is a French public administrative institution established to implement national health policy across regional territories, integrating missions from legacy bodies such as Assurance Maladie, Direction départementale des affaires sanitaires et sociales, and ARS predecessors. It operates within frameworks influenced by statutes including the Loi HPST (Hospital, Patients, Health and Territories Act) and interacts with institutions like Ministère des Solidarités et de la Santé, Conseil régional, Agence Nationale de Sécurité du Médicament et des Produits de Santé, and Haute Autorité de Santé. The ARS interfaces with municipal, departmental, and territorial actors such as Mairie de Paris, Conseil départemental de la Seine-Saint-Denis, and overseas collectivities including Guadeloupe, Martinique, and La Réunion.
The ARS system was created by the Loi du 21 juillet 2009 reform and implemented by the Loi HPST of 2009–2010 to replace predecessor bodies like the Assurance Maladie regional directorates, DDASS, and DAS units, aligning with reforms promoted by figures such as Nicolas Sarkozy and policy advisors from the Ministère de la Santé and IGAS (Inspection générale des affaires sociales). Its establishment followed international comparisons with institutions such as National Health Service in the United Kingdom, Robert Koch Institute in Germany, and regional health authorities like Aseptika-type organizations observed in Canada and Australia. Initial implementation raised debates in the Assemblée nationale and Sénat and involved stakeholders including Fédération Hospitalière de France, Confédération des Soins de Santé, and patient associations like Association Française des Diabétiques and Médecins Sans Frontières.
Each ARS is led by a director appointed by decree from the Conseil des ministres on proposals from the Ministre des Solidarités et de la Santé and operates under the supervision of the Ministère des Solidarités et de la Santé. Governance structures include regional boards and advisory committees drawing members from entities such as Agence nationale de santé publique, Haute Autorité de Santé, Caisse nationale d'assurance maladie, Union nationale des caisses d'assurance maladie, and representatives of professional orders like the Ordre des Médecins, Ordre des Infirmiers, and Ordre des Pharmaciens. The ARS coordinates with regional stakeholders including Agence de l'environnement et de la maîtrise de l'énergie, Conseil régional d'Île-de-France, Prefect of Police, and local hospital groups such as Assistance Publique–Hôpitaux de Paris and private providers like Korian and Orpea.
The ARS is charged with planning and implementing public health strategy, regulating healthcare provision, supervising healthcare establishments including Centre hospitalier universitaire, Clinique privée, and nursing homes, and responding to crises such as epidemics involving pathogens like SARS-CoV-2 and H1N1 influenza. It issues authorizations and accreditation processes interacting with Haute Autorité de Santé, enforces sanitary measures in contexts tied to agencies like Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail and coordinates vaccination campaigns with partners including Santé publique France, Institut Pasteur, and Caisse Primaire d'Assurance Maladie. The ARS also oversees health inequalities, home-care services with organizations such as ADMR and Santé au travail, and works with research institutions like Inserm, CNRS, and universities including Université Paris-Saclay and Université de Strasbourg.
Regional operations entail territorial health projects (Projet Régional de Santé) developed in consultation with actors like Fédération Hospitalière de France, Union Régionale des Professionnels de Santé, and local elected bodies including Conseil municipal. Coordination during emergencies links ARS to crisis management structures such as Préfecture, Direction générale de la sécurité civile et de la gestion des crises, and international cooperation channels involving World Health Organization and European Centre for Disease Prevention and Control. The ARS manages hospital networks, private clinics, primary care networks including Maisons de Santé Pluriprofessionnelles, and social care providers like Pôle emploi-connected services and associations including Croix-Rouge française and Secours populaire français. Regional partnerships extend to industrial and research stakeholders such as Sanofi, bioMérieux, Institut Pasteur de Lille, and territorial collectives like Collectivité territoriale de Corse.
ARS budgets derive from state allocations determined by the Ministère des Finances and programmatic credits tied to laws debated in the Assemblée nationale and Sénat. Funding flows interact with reimbursement mechanisms run by Caisse nationale d'assurance maladie and hospital tariffs set under T2A (tarification à l'activité), involving accounting rules from bodies like Cour des comptes and budget oversight by Direction générale du Trésor. Expenditure covers public hospital funding including CHU de Toulouse, support for private nursing providers like DomusVi, public health campaigns administered with Santé publique France, and investments in digital health platforms linked to initiatives such as Dossier médical partagé.
The ARS have been subject to evaluations by Cour des comptes, Inspection générale des affaires sociales, and parliamentary inquiries in the Assemblée nationale over issues including regional disparities, crisis responsiveness during events such as the COVID-19 pandemic and 2016 Nice attack, regulatory decisions affecting groups like Orpea and Korian, and tensions with professional orders including the Confédération des Syndicats Médicaux Français. Criticisms have addressed perceived centralization versus territorial subsidiarity debated by actors like Conseil d'État and regional elected officials from parties such as Les Républicains, La République En Marche!, and Parti Socialiste. Independent assessments from research centers such as Observatoire National de la Santé and think tanks like Fondation Jean-Jaurès and Institut Montaigne have recommended reforms to governance, transparency, and accountability involving parliamentary reviews and reforms proposed by ministers including Agnès Buzyn and Olivier Véran.
Category:Public health in France